Drug notes:
Undisclosed programs RD immuno-oncology, metabolic conditions, autoimmune conditions, genetic diseases
About:
Senda Biosciences is pursuing ‘intersystems’ biology to develop medicines. A grand vision in biology is to be able to program any cell in vivo, anywhere in the body, for any function. While many companies are developing methods to program _within the cell_, Senda is also trying to program _to the cell_. Programming to the cell involves understanding the molecule exchange between human and non-human cells that transfer information. Senda is using its ‘Senda Atlas’ platform to deconstruct nature’s code to program “information molecules” and natural nanoparticles with desired bioproperties. Information molecules include mRNA (SendRNA) , DNA, siRNA and gene editors and will enable Senda to target a wide range of currently unreachable cells and tissues in the body.
Jobs:
Head of Analytical Sciences Cambridge |1 day ago
Scientist I/II, Nanoparticle Formulations Cambridge |31 days ago
Senior Manager, Regulatory Affairs Cambridge |58 days ago
Scientist I/II, Integrative Biology (in vitro) Cambridge |100+ days ago
Deep Learning AI Lead (Director) Cambridge |100+ days ago